Dialysis patients and cardiovascular problems: Can technology help solve the complex equation?

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Biomedical Engineering

Background:

• Patients with end-stage kidney disease on chronic hemodialysis (HD) experience substantially elevated mortality rates.
• Cardiovascular disease accounts for approximately half of all deaths in HD patients, with a 30-fold higher risk of cardiovascular death compared to the general population.
• The increased cardiovascular burden in HD patients stems from uremic syndrome, traditional risk factors, and dialysis therapy-related issues.

Purpose of the Study:

• To explore the potential of 'cardioprotective dialysis therapy' by leveraging new technologies and advanced dialysis machines.
• To identify how innovations in dialysis can mitigate the cardiovascular risks associated with end-stage kidney disease treatment.

Main Methods:

• Review of existing literature on cardiovascular risks in hemodialysis patients.
• Analysis of features in advanced dialysis machines designed for improved patient monitoring and therapy delivery.
• Discussion of the role of online hemodiafiltration as a routine procedure.

Main Results:

• Advanced dialysis machines offer features for easier and safer patient monitoring.
• New technologies facilitate routine online hemodiafiltration, potentially improving dialysis tolerance.
• These advancements may enhance the efficiency of protecting patients from cardiovascular events.

Conclusions:

• Innovative dialysis technologies and advanced machines are crucial for developing 'cardioprotective dialysis therapy'.
• Improved patient monitoring and therapies like online hemodiafiltration can potentially reduce cardiovascular mortality in HD patients.
• Future directions should focus on integrating these advancements to optimize patient outcomes in chronic hemodialysis.